At the end of last year I wrote about 10 medical breakthroughs from 2025 you can read it here: This year Ill start with 5 major clinical trials to watch in 2026
Faster Recovery : By addressing nutritional deficiencies and supporting immune function, IV therapy may help shorten the duration of symptoms
While clinical reports document allodynia as an adverse effect, a parallel body of research shows that GLP-1 receptor agonists, including semaglutide, possess significant anti-pain and neuroprotective properties
10.1044/jshd.5504.656 29 LiuY.OkadaT.ShimazakiK.SheykholeslamiK.NomotoT.MuramatsuS.et al
Lipotropic injections have been a fixture of medical weight loss for decades, and they are one of the most requested cash-pay services in aesthetic and wellness practices
GLP-1 RA in Diabetes-Related AD and PD AD is an insidiously progressive ND clinically characterized by memory impairment, aphasia, apraxia, agnosia, impaired executive function, personality and behavior changes, and other comprehensive dementia manifestations